OCMS Bio has been selected to present at the Biotech Showcase during JPM Week 2025, as it continues to advance its cutting-edge biopharmaceutical innovations.

Held alongside the annual J.P. Morgan Healthcare Conference, Biotech Showcase is one of the industry’s feature investor conferences, bringing together executives, investors, and thought leaders from across the global life sciences sector. Being chosen to present highlights OCMS

Bio’s growing impact in biotechnology and underscores the promise of its groundbreaking research.

The company’s selection at Biotech Showcase provides a powerful platform to showcase its latest advancements, engage with key stakeholders, and explore strategic partnerships that will drive its next phase of growth.

“This recognition is a testament to our team’s dedication and the potential of our technology,” said Paul Halpern. “We are enthusiastic about sharing our vision with industry leaders and investors who can help accelerate our mission.”